503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.13%
Negative net income growth while ORCL stands at 13.04%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
8.60%
Some D&A expansion while ORCL is negative at -1.13%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
49.57%
Some yoy growth while ORCL is negative at -60.66%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-2.17%
Negative yoy SBC while ORCL is 4.03%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
197.37%
Well above ORCL's 87.58% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
192.69%
AR growth well above ORCL's 1.21%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-144.74%
Both reduce yoy inventory, with ORCL at -342.86%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-123.61%
Both negative yoy AP, with ORCL at -172.30%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
80.11%
Growth well above ORCL's 9.23%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
22.96%
Well above ORCL's 12.50%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
107.17%
Operating cash flow growth at 50-75% of ORCL's 183.47%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-34.01%
Both yoy lines negative, with ORCL at -9.92%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-107.25%
Both yoy lines negative, with ORCL at -3434.62%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-144.13%
Negative yoy purchasing while ORCL stands at 33.80%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
64.22%
Proceeds from sales/maturities above 1.5x ORCL's 23.76%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-92.84%
We reduce yoy other investing while ORCL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-354.71%
We reduce yoy invests while ORCL stands at 137.15%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
81.40%
We repay more while ORCL is negative at -44960.00%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
112.88%
We slightly raise equity while ORCL is negative at -47.96%. John Neff sees competitor possibly preserving share count or buying back shares.
83.21%
Repurchase growth above 1.5x ORCL's 3.92%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.